Annual Shareholders Equity
$452.97 M
+$568.11 M+493.40%
December 31, 2023
Summary
- As of February 7, 2025, GPCR annual stockholders equity is $452.97 million, with the most recent change of +$568.11 million (+493.40%) on December 31, 2023.
- During the last 3 years, GPCR annual shareholders equity has risen by +$475.44 million (+2115.96%).
- GPCR annual shareholders equity is now at all-time high.
Performance
GPCR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$896.80 M
-$24.23 M-2.63%
September 30, 2024
Summary
- As of February 7, 2025, GPCR quarterly stockholders equity is $896.80 million, with the most recent change of -$24.23 million (-2.63%) on September 30, 2024.
- Over the past year, GPCR quarterly shareholders equity has increased by +$703.84 million (+364.75%).
- GPCR quarterly shareholders equity is now -2.63% below its all-time high of $921.03 million, reached on June 30, 2024.
Performance
GPCR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
GPCR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +493.4% | +364.8% |
| 3 y3 years | +2116.0% | +364.8% |
| 5 y5 years | +2116.0% | +364.8% |
GPCR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +493.4% | -2.6% | +878.9% |
| 5 y | 5-year | at high | +493.4% | -2.6% | +878.9% |
| alltime | all time | at high | +493.4% | -2.6% | +878.9% |
Structure Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $896.80 M(-2.6%) |
| Jun 2024 | - | $921.03 M(+114.3%) |
| Mar 2024 | - | $429.82 M(-5.1%) |
| Dec 2023 | $452.97 M | $452.97 M(+134.7%) |
| Sep 2023 | - | $192.96 M(-10.0%) |
| Jun 2023 | - | $214.41 M(-9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $236.35 M(-305.3%) |
| Dec 2022 | -$115.14 M(+77.9%) | -$115.14 M(+10.8%) |
| Sep 2022 | - | -$103.91 M(+60.5%) |
| Dec 2021 | -$64.73 M(+188.1%) | - |
| Dec 2021 | - | -$64.73 M |
| Dec 2020 | -$22.47 M | - |
FAQ
- What is Structure Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Structure Therapeutics?
- What is Structure Therapeutics annual shareholders equity year-on-year change?
- What is Structure Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Structure Therapeutics?
- What is Structure Therapeutics quarterly shareholders equity year-on-year change?
What is Structure Therapeutics annual stockholders equity?
The current annual shareholders equity of GPCR is $452.97 M
What is the all time high annual shareholders equity for Structure Therapeutics?
Structure Therapeutics all-time high annual stockholders equity is $452.97 M
What is Structure Therapeutics annual shareholders equity year-on-year change?
Over the past year, GPCR annual stockholders equity has changed by +$568.11 M (+493.40%)
What is Structure Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of GPCR is $896.80 M
What is the all time high quarterly shareholders equity for Structure Therapeutics?
Structure Therapeutics all-time high quarterly stockholders equity is $921.03 M
What is Structure Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, GPCR quarterly stockholders equity has changed by +$703.84 M (+364.75%)